| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure
|
Chia, Yvonne May Fen
|
|
2018
|
23 |
3 |
p. 461-468
|
article
|
| 2 |
Clinical impact of oral antidiabetic medications in heart failure patients
|
Palazzuoli, Alberto
|
|
2018
|
23 |
3 |
p. 325-335
|
article
|
| 3 |
Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects
|
Kaplan, Abdullah
|
|
2018
|
23 |
3 |
p. 419-437
|
article
|
| 4 |
DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
|
Krittanawong, Chayakrit
|
|
2017
|
23 |
3 |
p. 355-361
|
article
|
| 5 |
Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment
|
Terlizzese, Paola
|
|
2018
|
23 |
3 |
p. 469-479
|
article
|
| 6 |
Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure
|
Anfinogenova, Yana
|
|
2017
|
23 |
3 |
p. 481-497
|
article
|
| 7 |
Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
|
Oikonomou, Evangelos
|
|
2018
|
23 |
3 |
p. 389-408
|
article
|
| 8 |
Molecular and clinical roles of incretin-based drugs in patients with heart failure
|
Orabi, Bassant
|
|
2018
|
23 |
3 |
p. 363-376
|
article
|
| 9 |
Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors
|
Bistola, Vasiliki
|
|
2018
|
23 |
3 |
p. 377-388
|
article
|
| 10 |
Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitus
|
Tanaka, Hidekazu
|
|
2018
|
23 |
3 |
p. 439-444
|
article
|
| 11 |
SGLT2 inhibition and heart failure—current concepts
|
Custodio, Joaquim Silva
|
|
2018
|
23 |
3 |
p. 409-418
|
article
|
| 12 |
Still sour about lactic acidosis years later: role of metformin in heart failure
|
Kuan, William
|
|
2017
|
23 |
3 |
p. 347-353
|
article
|
| 13 |
The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
|
Ofstad, Anne Pernille
|
|
2018
|
23 |
3 |
p. 303-323
|
article
|
| 14 |
The impact of oral anti-diabetic medications on heart failure: lessons learned from preclinical studies
|
Lambadiari, Vaia
|
|
2018
|
23 |
3 |
p. 337-346
|
article
|
| 15 |
The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus
|
Asleh, Rabea
|
|
2017
|
23 |
3 |
p. 445-459
|
article
|
Journal description